GE HealthCare Technologies Inc. (GEHC)
From Spin-Off To Standout: GE HealthCare Is Pretty Impressive
GE HealthCare's spin-off has unlocked valuation potential, allowing each former GE segment to thrive independently and attract market-specific growth. The company's Q3 showed steady revenue and margin gains, driven by operational efficiencies and growth in high-demand medical technologies. With advancements in AI and diagnostics, GE HealthCare is well-positioned to capture market share, though growth faces temporary headwinds in China.
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
GEHC's third-quarter results witness declining segmental revenues in imaging and ultrasound, offset by strong Pharmaceutical Diagnostics performance. The bottom line improves on better pricing.
GE HealthCare Technologies Inc. (GEHC) Q3 2024 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Robbie Marcus - J.P. Morgan Ryan Zimmerman - BTIG Joanne Wuensch - Citi David Roman - Goldman Sachs Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Sezgi Ozener - HSBC Navann Ty - BNP Paribas Operator Thank you for standing by, and welcome to GE HealthCare's Third Quarter 2024 Earnings Conference Call.
GE HealthCare (GEHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GE HealthCare's Profit Beats Estimates While China Sales Struggle
GE HealthCare (GEHC) reported better profits than expected for the third quarter as its sales were roughly in line with estimates.
GE HealthCare Technologies (GEHC) Tops Q3 Earnings Estimates
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.99 per share a year ago.
GE HealthCare beats Q3 profit estimates on U.S. demand for medical devices
GE HealthCare Technologies beat estimates for quarterly profit on Wednesday as strong demand for its medical devices in the U.S. offset slowing sales in China due to disruptions in the country's healthcare sector because of an anti-corruption drive.
Lower Volume Likely to Hurt GE HealthCare's Q3 Earnings
GEHC's third-quarter results are likely to witness declining segmental revenues in imaging, ultrasound and patient care. The bottom-line figure may reflect better pricing.
Unveiling GE HealthCare (GEHC) Q3 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for GE HealthCare (GEHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
What You Need To Know Ahead of GE HealthCare's Earnings
GE HealthCare (GEHC) is set to report earnings Wednesday morning, with analysts projecting revenue and profits to rise from the same time last year.
GEHC Stock Declines Despite the Unveiling of CareIntellect Application
GE Healthcare announces CareIntellect for Oncology to provide multi-modal patient data from disparate systems into a single view using generative AI.
GE HealthCare announces time-saving AI tool for doctors who treat cancer
GE HealthCare announced a new artificial intelligence application it said will save time for doctors who diagnose and treat cancer. The tool, called CareIntellect for Oncology, can quickly summarize patients' histories, monitor disease progression and identify relevant clinical trials, the company said.
